Building Local Capacity To Manufacture APIs
+254 706 438 475
apifa@apifa.org
Nairobi
Lavington,Ikigia
Monday - Friday 08h - 17h
Closed on Weekends
vulnerable medical product supply
chains are when relying on a small
number of manufacturers for
raw materialsand final products”
APIFA
Our Work
Transforming Pharmaceutical Manufacturing in Sub-Sahara Africa
Of all medicines consumed across sub-Sahara Africa only 20-30% are produced locally.
Our Work
Active Pharmaceutical Ingredients (APIs) are the actual drugs that are then formulated into tablets, liquids, capsules, or injections
Our Work
Enhancing Local Pharmaceutical Production of APIs and other HPTs
Supply disruptions of essential medicines become particularly acute during health emergencies such as in the case of the COVID-19 pandemic where the supply of most essential medicines and raw materials was significantly hampered.
About Us
API for Africa (APIFA) is a non-profit organization facilitating the local production of Active Pharmaceutical Ingredients (APIs) and other health products and technologies (HPTs) in sub-Sahara Africa. APIFA works with a multitude of critical stakeholders from the private sector, public sector, research institutes, and civil society, to address a major market challenge: the lack of not only API manufacturing capacity in sub-Sahara Africa, but also affordable medicines.
Engage With Us
Latest News
Emzor’s $23m plant to save dollars, save lives
The loan covers up to 60 percent of the project, which will initially focus on four anti-malaria APIs including artemether, lumefantrine, sulfadoxine, and pyrimethamine.
EIB Announces €14M to Emzor Pharmaceutical, Facilitated by APIFA
The partnership aims to address a long-standing challenge: the insufficient API manufacturing capacity in sub-Saharan Africa, coupled with the high cost of imported medicines
Essential API– Nigeria
The operation aims at increasing the manufacturing capacity of Active Pharmaceutical Ingredients (APIs) in Africa.
We Work With
Research Institution; to explore new innovations and products formulation.
International Partners: by leveraging on our partnerships to support local production.
Governments; to support the enhancement of quality and safety of medicines.
Local and Global Pharmaceutical Manufacturers: to enhance local production of medicines
Capital Providers: to secure affordable financing for local producers seeking to expand
Subscribe to our Updates
Sign up to stay updated on our latest news